Over 30 years of deep life sciences industry experience with a wide range of expertise in corporate governance, capital markets, licensing and strategic collaborations
Surana is a chartered accountant with an all-India rank.
He has published more than 100 research papers in several prestigious national and international journals
Allam was serving recently as the CEO at Public Investment Fund
Her previous role at Novartis, where she was general manager, data & digital, in global drug development, also included accountability for driving the DCT strategy, programs and platforms
Sanjeev is currently the Country President for AstraZeneca Malaysia
Spiro will be responsible for the overall strategy, implementation and growth of Lupin’s U.S. Generics business
Steve joins Sai Life Sciences from GlaxoSmithKline (GSK) where he was a department head and member of the global chemical development leadership team.
He brings over 30 years of experience across various organizations such as Asian Paints PPG, Berger Paints, Tata Steel, among others
Reinforcing GLC’s commitment to sustainable processing in pharmaceutical chemistry
Subscribe To Our Newsletter & Stay Updated
